Correspondence re:: Simon et al., Do thyroid disorders increase the risk of breast cancer?: 11:: 1574-1578, 2002 -: Reply

被引：0
|
作者：
Simon, MS
Tang, MTC
机构：
[1] Wayne State Univ, Karmanos Canc Inst, Div Hematol & Oncol, Detroit, MI USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2003年 / 12卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：685 / 686
页数：2
相关论文
共 50 条
  • [1] Correspondence re:: Simon et al., Do thyroid disorders increase the risk of breast cancer?: 11:: 1574-1578, 2002
    Altieri, A
    Tavani, A
    Gallus, S
    Bosetti, C
    Talamini, R
    Franceschi, S
    Levi, F
    La Vecchia, C
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (07) : 684 - 685
  • [2] Do thyroid disorders increase the risk of breast cancer?
    Simon, MS
    Tang, MTC
    Bernstein, L
    Norman, SA
    Weiss, L
    Burkman, RT
    Daling, JR
    Deapen, D
    Folger, SG
    Malone, K
    Marchbanks, PA
    McDonald, JA
    Strom, BL
    Wilson, HG
    Spirtas, R
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (12) : 1574 - 1578
  • [3] Correspondence re:: Welzel et al., Cancer Res., 61:: 1629-1636. -: Reply
    Welzel, N
    Nadel, B
    Jaeger, U
    [J]. CANCER RESEARCH, 2003, 63 (07) : 1723 - 1723
  • [4] Reply to correspondence to the editor by de Wit et al. - "Re: Polymicrogyria versus pachygyria in 22q11 deletion"
    Ehara, H
    Ehara, H
    Maegaki, Y
    Takeshita, K
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 136A (04) : 421 - 421
  • [5] Re: "Symptomatic Biliary Disorders During Lenvatinib Treatment for Thyroid Cancer: An Underestimated Problem" by Nervo et al.
    Agate, Laura
    Puleo, Luciana
    Giani, Carlotta
    Valerio, Laura
    Molinaro, Eleonora
    Elisei, Rossella
    [J]. THYROID, 2021, 31 (02) : 330 - 331
  • [6] Correspondence re:: Somasundaram et al., Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res., 62: 3868-3875, 2002.: Reply
    Orlowski, RZ
    [J]. CANCER RESEARCH, 2003, 63 (16) : 5166 - 5167
  • [7] Re: Sharma et al. dysplasia and cancer risk of short-segment Barrett's esophagus - Reply
    Sharma, P
    Sampliner, RE
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (12): : 2640 - 2641
  • [8] Correspondence re:: A.!Muller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer.: Cancer Res., 62: 1014-1019, 2002.
    de Leeuw, WJF
    van Puijenbroek, M
    Tollenaar, RAEM
    Cornelisse, CJ
    Vasen, HFA
    Morreau, H
    [J]. CANCER RESEARCH, 2003, 63 (05) : 1148 - 1149
  • [9] Correspondence re:: Feyler et al., point:: Myeloperoxidase -463G→A polymorphism and lung cancer risk.: Cancer Epidemiol. Biomark. Prev., 11:: 1550-1554, 2002, and Xu et al., counterpoint:: The myeloperoxidase -463G→A polymorphism does not decrease lung cancer susceptibility in caucasians.: 11:: 1555-1559, 2002
    Dally, H
    Bartsch, H
    Risch, A
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (07) : 683 - 683
  • [10] Correspondence re:: C. G.!Ferreira et al., Apoptosis:: Target of cancer therapy.: Clin. Cancer Res., 8: 2024-2034, 2002.: Reply
    Ferreira, CG
    Epping, M
    Kruyt, FAE
    Giaccone, G
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (02) : 913 - 914
12345